GHRP-2: molecular data, studies & sources

Molecular formula, weight & structure

Molecular formula (MF)

C45H55N9O6

Molecular weight (MW)

818.0 g/mol

PubChem compound ID

6918245

Record title

Pralmorelin

Values describe the selected PubChem molecular entity. Counterions, salt forms, hydration and sequence changes can alter the supplied material. Confirm the exact identity against the supplier specification.

Source: PubChem CID 6918245 · retrieved 2026-09-21

US regulatory status & drug development

Drugs@FDA lists no NDA, BLA or ANDA with pralmorelin as an active ingredient (names searched: PRALMORELIN, PRALMORELIN DIHYDROCHLORIDE, GHRP-2; checked October 7, 2026). Research-labelled GHRP-2 listings are not FDA-approved drugs.

An FDA approval covers a defined medicine, formulation and labelled use. It does not extend to research-labelled material sold under the same compound name. Identity basis: INN pralmorelin, its dihydrochloride and the code GHRP-2 were searched.

Source: Drugs@FDA via openFDA (active-ingredient search for PRALMORELIN, PRALMORELIN DIHYDROCHLORIDE, GHRP-2) · checked 2026-10-07. openFDA data are not intended for clinical decisions.

Registered clinical trials

Studies registered on ClinicalTrials.gov that list GHRP-2 as an intervention. Studies that only measure the molecule as a biomarker, or use it only as a comparator or background arm for another drug, are excluded. A registration describes a planned or completed protocol; it does not report a result. Active studies are listed first.

No registered study naming this compound was matched. This is a documented gap in registry coverage, not proof that no study exists.

Registry check 2026-10-01 · Run this search on ClinicalTrials.gov

Human intervention studies

Selected studies in which participants received GHRP-2, with their indexed or reviewed study type. Check the original article for the formulation, population and controls. Studies that only measured the molecule, or used it as a comparator, are listed separately below and are not counted as intervention studies.

1. Human study · PubMed trial index Compound given to participants

   GHRP-2, GHRH and SRIF interrelationships during chronic administration of GHRP-2 to humans.

   Bowers CY, Granda-Ayala R · Journal of pediatric endocrinology & metabolism : JPEM · 1996

   PMID 8887169

2. Human study · PubMed trial index Compound given to participants

   The combined administration of GH-releasing peptide-2 (GHRP-2), TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP-2 alone.

   Van den Berghe G, Baxter RC, Weekers F et al. · Clinical endocrinology · 2002

   PMID 12030918 · DOI: 10.1046/j.1365-2265.2002.01255.x

Preclinical research, reviews & other publications

Animal studies, laboratory experiments, reviews and other indexed papers answer different questions. A review is secondary evidence; a case report does not estimate how often an outcome occurs.

1. Review · secondary evidence

   Pralmorelin: GHRP 2, GPA 748, growth hormone-releasing peptide 2, KP-102 D, KP-102 LN, KP-102D, KP-102LN.

   · Drugs in R&D · 2004

   PMID 15230633 · DOI: 10.2165/00126839-200405040-00011

2. Research publication · design requires review

   Determination of growth hormone secretagogue pralmorelin (GHRP-2) and its metabolite in human urine by liquid chromatography/electrospray ionization tandem mass spectrometry.

   Okano M, Sato M, Ikekita A et al. · Rapid communications in mass spectrometry : RCM · 2010

   PMID 20552695 · DOI: 10.1002/rcm.4619

3. Preclinical / laboratory research

   Pharmacological characteristics of KP-102 (GHRP-2), a potent growth hormone-releasing peptide.

   Doi N, Hirotani C, Ukai K et al. · Arzneimittel-Forschung · 2004

   PMID 15646370 · DOI: 10.1055/s-0031-1297041

4. Research publication · design requires review

   Determination of growth hormone releasing peptides metabolites in human urine after nasal administration of GHRP-1, GHRP-2, GHRP-6, Hexarelin, and Ipamorelin.

   Semenistaya E, Zvereva I, Thomas A et al. · Drug testing and analysis · 2015

   PMID 25869809 · DOI: 10.1002/dta.1787

5. Research publication · design requires review

   Growth hormone releasing peptide-2 (GHRP-2), like ghrelin, increases food intake in healthy men.

   Laferrère B, Abraham C, Russell CD et al. · The Journal of clinical endocrinology and metabolism · 2005

   PMID 15699539 · DOI: 10.1210/jc.2004-1719

6. Research publication · design requires review

   Detection of GHRP-2 and GHRP-6 in urine samples from athletes.

   Cox HD, Hughes CM, Eichner D et al. · Drug testing and analysis · 2015

   PMID 25809000 · DOI: 10.1002/dta.1791

GHRP-2 supplier sources

Scientific sources describe molecules and experiments. The commercial links below identify recorded supplier packages. A publication or chemical database entry does not verify the seller, purity, sterility or contents of a lot. Some links are affiliate links; see our disclosure.

GHRP-2 for sale: compare prices, sizes and forms from every tracked supplier →

Reference sources & further reading

• PubChem compound record 6918245 — chemical identity and structure.
• ChEMBL drug record CHEMBL106593 — development stage, mechanism and synonyms.
• FDA Global Substance Registration System: UNII E6S6E1F19M — substance identity, names and codes.
• Wikipedia: Pralmorelin — Background encyclopedia; not a primary clinical source.

The citations above link directly to publication records. Encyclopedia links are background reading and are not used to establish clinical effectiveness.

Research information is not a dosing guide or a recommendation for personal use. Study findings are specific to the formulation, population and methods tested. Read our source and correction policy.

Related research profiles